HIV-virus

Division of Infectious Diseases

Noteworthy Publications

Henman LJ, Corrigan R, Carrico R, Suh KN. Practice Analysis Survey Development Team, Practice Analysis Review and Test Specification Development Team. Identifying changes in the role of the infection preventionist through the 2014 practice analysis study conducted by the Certification Board of Infection Control and Epidemiology, Inc. Am J Infect Control 2015;43(7):664–8.

Cowan J, Gaudet L, Mulpuru S, Corrales-Medina V, Hawken S, Cameron C, Aaron SD, Cameron DW. A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease. PLoS One 2015;10(11):e0142205.

Angel JB, Routy JP, Graziani GM, Tremblay CL. The Effect of Therapeutic HIV Vaccination With ALVAC-HIV With or Without Remune on the Size of the Viral Reservoir (A CTN 173 Substudy). J Acquir Immune Defic Syndr 2015;70(2);122–8.

Corsi DJ, Karges W, Thavorn K, Crawley AM, Cooper C. Influence of female sex on hepatitis C virus infection progression and treatment outcomes. Eur J Gastroenterol Hepatol 2016;28(4):405–11.

Corrales-Medina VF, Taljaard M, Yende S, Kronmal R, Dwivedi G, Newman AB, Elkind MS, Lyles MF, Chirinos JA. Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults. Am Heart J 2015; 170(2):306–12.

 

Key Grants

July 2016–June 2018. Heart & Stroke Foundation of Canada ($152,576).

“Vascular inflammation after acute pneumonia as measured by 18FDG-PET/CT scan”. Principal Investigator: V.F. Corrales Medina

2016–2017. CIHR ($150,000). “Gay Positive Sex: Adaptation of an HIV prevention counseling program for HIV-positive and HIV-negative gay and bisexual men”. Principal Investigators: T.A. Hart, O.J. McEwan, N.J. Lachowsky, P.A. MacPherson

2016–2017. CIHR ($150,000). “Adaptation of a structural intervention to improve access to combination HIV prevention for men who have sex with men in four Canadian cities”. Principal Investigators: J. Otis, J. Jollimore, P.A. MacPherson, D.H. Tan

March 2016–March 2018. TOHAMO ($100,000). “Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Patients with Frequent Exacerbations: A Pilot Study”. Principal Investigators:J. Cowan, B. Cameron

2016–2017. TOHAMO ($99,976). “Improving physician antibiotic prescribing behavior: empowering infectious diseases physicians to influence changes in practice among their peers”. Principal Investigators: K. Suh, J. Grimshaw, F. Auclair, S. Boet, A. Forster, P. Hendry, C. Nott, J. Presseau, J. Squires

 

 

 

Overview

The Division of Infectious Diseases at the Ottawa Hospital/University of Ottawa is a highly academic division committed to quality patient care which is the foundation of clinical and basic science research and which leads to quality improvement in our patient care.  The division is involved in the education of medical students at all levels, Masters and PhD candidates, interns and residents and Infectious Disease fellows.  The division has a mandate to provide regional infectious disease consultation as well as regional infection control advice to the entire Champlain region of Eastern Ontario and West Quebec.

Key regional programs are:

  1. Immunodeficiency Clinic which provides multidisciplinary care for HIV/AIDS patients.
  2. Regional TB Program in collaboration with Ottawa Public Health,
  3. Regional Multidisciplinary Viral Hepatitis Program,
  4. Hospital and Regional Infection Control Program
  5. Infectious Disease inpatient and outpatient consultation based at both the Civic and General campuses with affiliation to the Queensway Carleton, Montfort and Elizabeth Bruyère Continuing Care.

Research

Research is a major focus of the Infectious Diseases division and this has resulted in high impact publications and continued success with grant applications.  The research interests of the division members are varied and cover a range of topics with special focus on HIV, hepatitis C, sexually transmitted infections, hospital-based infection control and infections occurring in international settings.  The over-riding goal is to conduct research that is highly translational and results in improved patient outcomes.

read more

Education

The division has a robust Royal College Infectious Disease training program which has one to two new recruits per year.  The program has an outstanding reputation in providing residents/fellows with an educational program targeted to their needs and career aspirations.  Medical students at all levels do electives both on inpatient and outpatient clinics.  It is a highly sought after elective.  Interested students should consider applying as soon as possible to secure their desired time slot.

Patient Care

Infectious Diseases provides both inpatient consultation services and outpatient clinics at each of the Civic and General campuses of The Ottawa Hospital. Our clinics provide an enriching environment for training medical students and residents. A strong clinical research program is integrated into this clinical care as well.

read more

Recent Notable Honours and Achievements:

  • Dr. Bill Cameron—Appointed Medical Director, Clinical Research, OHRI
  • Dr. Paul MacPherson—Appointed Director, Clinician Investigator Program, University of Ottawa
  • Dr. Paul MacPherson—OHTN Research Chair in Gay Men’s Health (2016–2021)